title: In-vitro tipranavir susceptibility of HIV-1 isolates with reduced susceptibility to other protease inhibitors.
authors.forename: N K
authors.initials: NK
authors.lastname: Back
authors.forename: A
authors.initials: A
authors.lastname: van Wijk
authors.forename: D
authors.initials: D
authors.lastname: Remmerswaal
authors.forename: M
authors.initials: M
authors.lastname: van Monfort
authors.forename: M
authors.initials: M
authors.lastname: Nijhuis
authors.forename: R
authors.initials: R
authors.lastname: Schuurman
authors.forename: C A
authors.initials: CA
authors.lastname: Boucher
mesh_terms: D000595:Amino Acid Sequence; D004352:Drug Resistance, Microbial; D017320:HIV Protease Inhibitors / Q000494:pharmacology*; D015497:HIV-1 / Q000187:drug effects* / Q000235:genetics / Q000302:isolation & purification; D020128:Inhibitory Concentration 50; D008826:Microbial Sensitivity Tests; D008969:Molecular Sequence Data; D011725:Pyridines / Q000494:pharmacology*; D011753:Pyrones / Q000494:pharmacology*; D012367:RNA, Viral / Q000032:analysis; D020133:Reverse Transcriptase Polymerase Chain Reaction; D013449:Sulfonamides
chemical_list: D017320:HIV Protease Inhibitors; D011725:Pyridines; D011753:Pyrones; D012367:RNA, Viral; D013449:Sulfonamides; C107201:tipranavir